ライフサイエンスコーパス: dysrhythmia

1 ith potassium-sensitive weakness and cardiac dysrhythmia.

2 or reducing pulmonary artery distortion and dysrhythmia.

3 y to any of its components can cause cardiac dysrhythmia.

4 ed thalamic burst firing and thalamocortical dysrhythmia.

5 altered thalamic firing and thalamocortical dysrhythmia.

6 ith gating error caused by pacemaker-induced dysrhythmia.

7 uction of triggered activity and ventricular dysrhythmia.

8 a genetic susceptibility to developing this dysrhythmia.

9 One patient developed unstable cardiac dysrhythmia.

10 hyxia with that of cardiac arrest induced by dysrhythmia.

11 k of acute myocardial infarction or unstable dysrhythmia.

12 the SR can initiate various types of atrial dysrhythmias.

13 to the heart for termination of ventricular dysrhythmias.

14 show desensitization to nicotine-stimulated dysrhythmias.

15 rate of the heart, thereby promoting cardiac dysrhythmias.

16 otility disorders associated with electrical dysrhythmias.

17 increased propensity for lethal ventricular dysrhythmias.

18 syncopal episodes attributed to ventricular dysrhythmias.

19 opressin-induced emetic response and gastric dysrhythmias.

20 m circulatory diseases, specifically cardiac dysrhythmias.

21 vel mechanism for the development of cardiac dysrhythmias.

22 ave well-known pathogenetic roles in cardiac dysrhythmias.

23 ufficiency, respiratory failure, and cardiac dysrhythmias.

24 andidate genes in studies of human circadian dysrhythmias.

25 lt in disruption of ICC and gastrointestinal dysrhythmias.

26 thrombotic disorders [0.78 (0.74-0.83)], and dysrhythmia [0.79 (0.77-0.81)].

27 localized conduit necrosis (19%), and atrial dysrhythmia (15%).

28 .9, P<0.001), stroke (4.7 vs. 3.1, P<0.001), dysrhythmia (20.9 vs. 11.0, P<0.001), and any cardiovasc

29 Of the 724 hospitalizations for cardiac dysrhythmias, 203 were in the potentially exposed group,

30 (14.4%-20.1%), anemia (12.4%-20.4%), cardiac dysrhythmias (21.7%-29.0%), congestive heart failure (40

31 mplications of left atrial (LA) myopathy and dysrhythmia across the spectrum of AF burden in HFpEF.

32 and who had no cardiovascular complications (dysrhythmias, acute myocardial infarction, or recurrent

33 rval [CI]: 0.63 to 0.86; p < 0.001), cardiac dysrhythmia (adjusted OR: 0.72; 95% CI: 0.55 to 0.94; p

34 During the observation period, there were no dysrhythmia adverse events.

35 tempt at intubation, hypotension, or cardiac dysrhythmia) after the study treatment was administered

36 ngestive heart failure; and poor (<0.36) for dysrhythmia, ambulation status, pericarditis, chronic ob

37 gested involvement of inflammation with this dysrhythmia, an initiating factor for inflammation has b

38 fibrillation (AF) is the most common cardiac dysrhythmia and a source of considerable morbidity and m

39 yopathy was associated with a propensity for dysrhythmia and characterized by overt intracellular cal

40 ncluded evidence of stronger associations of dysrhythmia and congestive heart failure visits with com

41 nce that rats exhibit stress-induced cardiac dysrhythmia and ischemia sensitivity comparable to human

42 onents of PCC) in the cardiovascular system (dysrhythmia and ischemic heart disease), coagulation and

43 associations for phecodes including cardiac dysrhythmia and metabolic syndrome, thereby indicating p

44 ve pulmonary disease (COPD) was observed for dysrhythmia and peripheral and cerebrovascular disease v

45 nstrable significant correlation between the dysrhythmia and various biomarkers of inflammation.

46 Pediatric brady-dysrhythmias and conduction disorders are uncommon, but

47 le of preventing vasopressin-induced gastric dysrhythmias and gastric slow wave uncoupling.

48 titial cells of Cajal (ICC), which may cause dysrhythmias and impaired neural control.

49 nterval and increase the risk of ventricular dysrhythmias and sudden death.

50 rction, Bundle Branch Block, Cardiomyopathy, Dysrhythmia, and Hypertrophy.

51 in AF when symptoms are simply attributed to dysrhythmia, and incident AF may identify patients at ri

52 n, left ventricular diastolic heart disease, dysrhythmia, and sudden death.

53 activity, a self-sustaining thalamocortical dysrhythmia, and the constant perception of pain.

54 may increase the risk of infection, cardiac dysrhythmias, and bleeding, all complications independen

55 typies, anxiety, tremor, ataxia, respiratory dysrhythmias, and seizures.

56 infarction, left-ventricular dysfunction, or dysrhythmia; and chronically-by accelerating the atheros

57 ion, ischemic stroke, heart failure, cardiac dysrhythmias, angina pectoris, and peripheral artery dis

58 in RSV hospitalizations vs boosted COVID-19 (dysrhythmia: AOR, 1.52; 95% CI, 1.19-1.94; heart failure

59 d procedures (eg, transient ischemic attack, dysrhythmia, aortic valve replacement, and femoral popli

60 ing that mechanisms regulating recovery from dysrhythmia are likely to be distinct from cardiac regen

61 Disrupted ICC networks and gastric dysrhythmias are each associated with gastroparesis.

62 Postoperative dysrhythmias are most likely to occur in patients with s

63 m slowed and ABP increased, (2) a tachypnoea/dysrhythmia area, at the level of the preBotzinger compl

64 taphylococcus as the causative organism, and dysrhythmias as a comorbid condition.

65 s have raised the possibility of ventricular dysrhythmias as the cause of these deaths.

66 dia (beta = 0.045; P = 8.30 x 10-5), cardiac dysrhythmias (beta = 0.016, P = 3.09 x 10-5), and acute

67 or mortality, 1.5; 95% CI, 1.1-2.1), cardiac dysrhythmias (beta coefficient, 1.8; 95% CI, 1.1-2.6; OR

68 atment of electromechanical dyssynchrony and dysrhythmia by cardiac resynchronisation and implantable

69 isorder termed Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome.

70 linical evidence of severe myocarditis, with dysrhythmias, cardiomegaly, and cardiogenic shock.

71 pulmonary fibrosis, pulmonary hypertension, dysrhythmias, cardiomyopathy, hypercalcemia, and renal f

72 ed abnormal electrocardiogram (EKG), cardiac dysrhythmias, cerebrovascular disease, non-epithelial sk

73 uency, meaning that the varying amplitude of dysrhythmia could predispose patients to recurrent attac

74 sion, acute coronary syndrome (ACS), cardiac dysrhythmia, CV death, cerebrovascular event, and venous

75 ignificantly higher risk of anosmia, cardiac dysrhythmia, diabetes, genitourinary disorders, malaise,

76 habituation, putatively by reducing gastric dysrhythmias during incentivized engagement with disgust

77 C accumulation may contribute to ventricular dysrhythmias during ischemia.

78 Atrial fibrillation is the most common dysrhythmia encountered in clinical practice.

79 lity attributable to ischemic heart disease, dysrhythmias, heart failure, and cardiac arrest.

80 psychosis, lethargy, seizures, tachycardia, dysrhythmias, hypertension, and hyperthermia.

81 This current may contribute to dysrhythmias, hypertrophy, and altered contractile funct

82 orrection algorithm on the pacemaker-induced dysrhythmia image set to see whether it repaired this se

83 hm accurately repaired the pacemaker-induced dysrhythmia image set; when it was applied to the 64-pat

84 e occurred in 6 subjects (0.65%), because of dysrhythmia in 2, device embolization in 1, and cardiac

85 findings on thalamocortical dysfunction and dysrhythmia in chronic pain and demonstrate that cLBP pa

86 fibrillation (AF) is the most common cardiac dysrhythmia in the United States.

87 cortex and hippocampus in vitro and cortical dysrhythmia in vivo.

88 duction abnormalities and sudden ventricular dysrhythmias in pediatric patients taking psychotropic d

89 latory heart rhythm monitor alone, non-AFACS dysrhythmias, in-patient mortality, or length of stay.

90 Dysrhythmias included abnormalities of initiation (stabl

91 T-channels may contribute to thalamocortical dysrhythmia, including absence epilepsy.

92 Thalamocortical dysrhythmia is a key pathology of chronic neuropathic pa

93 of the circadian system, known as circadian dysrhythmia, is increasingly common.

94 e cardiac events, cerebrovascular disorders, dysrhythmia, ischemic heart disease, and other cardiac d

95 gories, including cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, p

96 cardiovascular conditions in 10%, including dysrhythmia, left pulmonary artery thrombosis, and chron

97 iorespiratory arrest from underlying cardiac dysrhythmia may be a cause.

98 Severe myocardial dysfunction and dysrhythmias may accompany respiratory syncytial virus i

99 es was significantly associated with cardiac dysrhythmia, metabolic syndrome, disc disorders/dorsopat

100 with sepsis are prone to developing cardiac dysrhythmias, most commonly atrial fibrillation.

101 hile secondary outcomes consisted of stroke, dysrhythmia, myocardial infarction, thrombosis, pneumoni

102 ntolerance, hypertrophic cardiomyopathy with dysrhythmia, myotonic myopathy and hypotension, all dist

103 f superficial wound complications and atrial dysrhythmias, obesity is not a significant multivariate

104 in these translational models is that human dysrhythmia occurs while SCN circuitry is genetically an

105 al pathways leading to epilepsy, an episodic dysrhythmia of the cerebral cortex marked by abnormal ne

106 upport a model that attributes tinnitus to a dysrhythmia of the thalamocortical loop, leading to hypo

107 Dysrhythmias of breathing occur in several clinical diso

108 ein-losing enteropathy, thromboembolism, and dysrhythmias often lead to significant morbidity and mor

109 s but evokes prostaglandin-dependent gastric dysrhythmias only in nonsmokers.

110 tion was not associated with any increase in dysrhythmias or adverse clinical outcomes.

111 benefits when selected for the treatment of dysrhythmias or chronic pain in patients with coexisting

112 Electrogastrography may identify dysrhythmias or failure of signal power to increase post

113 nt (AOR, 1.58; 95% CI, 1.24-2.01) as well as dysrhythmias or heart failure were observed in patients

114 including stroke (OR 1.5250, p = 0.0067) and dysrhythmia (OR 1.5650, p = 0.0494), compared to those w

115 disease, stroke, peripheral artery disease, dysrhythmias, or heart failure), ascertained by Internat

116 ions (P = .005; odds ratio, 1.8), and atrial dysrhythmias (P = .04; odds ratio, 1.2).

117 Atrial dysrhythmia patients have exaggerated intra-atrial condu

118 ital SND characterized by bradycardia, sinus dysrhythmia, prolonged sinoatrial node recovery time, in

119 risk of eight of the 13 post-acute sequelae: dysrhythmia, pulmonary embolism, deep vein thrombosis, f

120 was an intrinsic property of ICC and whether dysrhythmias result from disruptions of ICC networks.

121 , 1.93; 95% CI, 1.43-1.60; P < .01), cardiac dysrhythmia (RR, 1.64; 95% CI, 1.23-2.17; P < .001), cer

122 16, 2023, patients with no history of atrial dysrhythmias scheduled for isolated coronary artery bypa

123 that clinically important cardiomyopathy and dysrhythmia secondary variants can be identified in unse

124 lex cardiac phenotype characterized by sinus dysrhythmia, severe sinus bradycardia, sinus pauses and

125 7 cycles/min), and tachygastric frequencies; dysrhythmias showed velocity anisotropy (mean, 3.3 mm/s

126 c disorders characterized by thalamocortical dysrhythmia, such as CAE.

127 dentify CAID syndrome as a novel generalized dysrhythmia, suggesting a new role for SGOL1 and the coh

128 sfunction is commonly associated with atrial dysrhythmia (tachy-brady syndrome) and is a particularly

129 aracterized by Chronic Atrial and Intestinal Dysrhythmia, termed CAID syndrome, in 16 French Canadian

130 ythms in the stomach,(9-13) inducing gastric dysrhythmias that correlate with neural signatures of di

131 a dose (10 mg) that acts to convert gastric dysrhythmias to normal rhythms.(9) In a preregistered, r

132 Vasopressin induced gastric dysrhythmias, uncoupling of slow waves, and vomiting and

133 er, we found an increased risk of other CVD (dysrhythmia, valvular dysfunction, and pericarditis) (ad

134 D), such as atherothrombosis, heart failure, dysrhythmias, vessel calcification and dysregulated angi

135 1 and If in generating stable pacemaking and dysrhythmias was evaluated.

136 Rates of dysrhythmia were higher.

137 lence and associated factors for ventricular dysrhythmias were defined.

138 he recovery period was shorter, symptoms and dysrhythmias were fewer, hypertension and hypotension we

139 Slow-wave dysrhythmias were identified in all 9 subjects with CUNV

140 Gastric dysrhythmias were more frequent on postoperative day 3 (

141 days, damage to ICC networks and electrical dysrhythmias were observed.

142 of relatives, whereas other supraventricular dysrhythmias were present in 16%.

143 field, respectively; P < .05), but slow-wave dysrhythmias were similar between groups.

144 and chronic pain may reflect thalamocortical dysrhythmia, which results from abnormal theta-range res

145 a indicate the presence of a thalamocortical dysrhythmia, which we propose is responsible for all the

146 fibrillation after cardiac surgery remains a dysrhythmia with significant implications.

147 ce in the treatment of patients with cardiac dysrhythmias with the introduction of radiofrequency abl